SUBSCRIBE
SUBSCRIBE
News   Business

Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors

July 8, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
A crushing blow to business and economic growth. Stopping income rise and welfare growth. Mitigate dangers and reduce risks. Anticipate the main blow of the crisis. End of career. Bankruptcy.
Earnings
BioNTech cuts sales forecast on slumping demand for COVID-19 vaccine
August 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Supernus, Indivior merger expected to result in ‘natural redundancies’
August 4, 2026
 · 
71 min read
 · 
BioSpace Editorial Staff
Pictured: Series of outcroppings with steep cliffs
Business
As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger
August 4, 2026
 · 
3 min read
 · 
Gabrielle Masson
AI and business savings concept. Vector of a robot hand holding sack of money and businessman loosing profit due to inefficient management
Earnings
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
August 4, 2026
 · 
3 min read
 · 
Annalee Armstrong